(Q45078598)

English

Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation

scientific article published on 24 September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Adrian Newman-Tancredi

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Mark S Kleven

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Marie-Bernadette Assié

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cristina Cosi

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Catherine Barret-Grévoz

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

24 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

177

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

373-380

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-004-1970-z

0 references

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT(1A) receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ?2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonergic involvement in haloperidol-induced catalepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of L-DOPA on evoked dopamine release in rat striatum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine a

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine reversal of the deficits in coordinated movement induced by D2 receptor blockade does not depend upon antagonism of alpha2 adrenoceptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT1A receptor agonists: recent developments and controversial issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of idazoxan on forskolin-stimulated adenylate cyclase activity through 5-hydroxytryptamine1A receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The alpha 2-adrenoceptor antagonist idazoxan is an agonist at 5-HT1A autoreceptors modulating serotonin synthesis in the rat brain in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15448976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-004-1970-Z

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45078598&oldid=2065302778"